David Jakeman - Feb 4, 2022 Form 4 Insider Report for CHIMERIX INC (CMRX)

Role: Principal Accounting Officer
Signature: /s/ Michael Alrutz, Attorney-in-Fact
Stock symbol: CMRX
Transactions as of: Feb 4, 2022
Transactions value $: -$18,355
Form type: 4
Date filed: 2/4/2022, 05:07 PM
Previous filing: Jan 20, 2022
Next filing: Sep 30, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMRX	Common Stock	Sale	-$18.4K	-3.3K	-2.73%	$5.56^*	118K	Feb 4, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to restricted stock unit awards granted on January 25, 2018, January 23, 2019, January 21, 2020 and January 22, 2021. The sales of the shares were made pursuant to automatic sell-to-cover arrangements adopted pursuant to Rule 10b5-1 under the Exchange Act in connection with the grants of such restricted stock unit awards.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.56 to $5.565, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Content

The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to restricted stock unit awards granted on January 25, 2018, January 23, 2019, January 21, 2020 and January 22, 2021. The sales of the shares were made pursuant to automatic sell-to-cover arrangements adopted pursuant to Rule 10b5-1 under the Exchange Act in connection with the grants of such restricted stock unit awards.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.56 to $5.565, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.